High Tower Advisors, LLC Bio N Tech Se Transaction History

High Tower Advisors, LLC

$68.3 Billion
Q3 2024

A detailed history of High Tower Advisors, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, High Tower Advisors, LLC holds 13,560 shares of BNTX stock, worth $1.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,560

Previous 14,360 5.57%

Holding current value

$1.61 Million

Previous $1.15 Million 39.64%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$78.36 - $124.66 $62,688 - $99,728	-800 Reduced 5.57%	13,560 $1.61 Million
Q2 2024 Aug 13, 2024	SELL	$80.36 - $102.87 $299,903 - $383,910	-3,732 Reduced 20.63%	14,360 $1.15 Million
Q1 2024 May 06, 2024	BUY	$88.96 - $112.35 $24,108 - $30,446	271 Added 1.52%	18,092 $1.67 Million
Q4 2023 Feb 12, 2024	BUY	$90.91 - $112.75 $723,370 - $897,151	7,957 Added 80.67%	17,821 $1.88 Million
Q3 2023 Nov 08, 2023	SELL	$98.5 - $125.08 $730,968 - $928,218	-7,421 Reduced 42.93%	9,864 $1.07 Million
Q2 2023 Aug 14, 2023	BUY	$102.58 - $129.66 $241,883 - $305,738	2,358 Added 15.8%	17,285 $1.87 Million
Q1 2023 May 11, 2023	BUY	$122.57 - $153.67 $1.04 Million - $1.3 Million	8,472 Added 131.25%	14,927 $1.86 Million
Q4 2022 Feb 08, 2023	BUY	$118.43 - $186.05 $106,942 - $168,003	903 Added 16.26%	6,455 $969,000
Q3 2022 Nov 09, 2022	SELL	$127.65 - $183.11 $81,057 - $116,274	-635 Reduced 10.26%	5,552 $744,000
Q2 2022 Aug 10, 2022	SELL	$123.25 - $186.24 $246 - $372	-2 Reduced 0.03%	6,187 $924,000
Q1 2022 May 12, 2022	SELL	$126.25 - $231.85 $1.39 Million - $2.55 Million	-10,979 Reduced 63.95%	6,189 $1.06 Million
Q4 2021 Feb 10, 2022	SELL	$216.64 - $362.52 $595,543 - $996,567	-2,749 Reduced 13.8%	17,168 $4.43 Million
Q3 2021 Nov 12, 2021	BUY	$205.93 - $447.23 $3.9 Million - $8.47 Million	18,939 Added 1936.5%	19,917 $5.44 Million
Q2 2021 Aug 06, 2021	SELL	$113.32 - $241.49 $158,987 - $338,810	-1,403 Reduced 58.92%	978 $218,000
Q1 2021 May 10, 2021	BUY	$85.73 - $119.5 $204,123 - $284,529	2,381 New	2,381 $259,000
Q4 2020 Feb 10, 2021	SELL	$72.71 - $129.54 $433,206 - $771,799	-5,958 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$57.81 - $104.17 $8,902 - $16,042	154 Added 2.65%	5,958 $412,000
Q2 2020 Aug 10, 2020	BUY	$38.58 - $66.74 $223,918 - $387,358	5,804 New	5,804 $387,000

Others Institutions Holding BNTX

# of Institutions

357

Shares Held

38.3M

Call Options Held

2.45M

Put Options Held

2.29M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28.8B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Bio N Tech Se Transaction History